{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:14:37Z","timestamp":1791918877419,"version":"4.3.4"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T00:00:00Z","timestamp":1172620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0000238","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T22:30:25Z","timestamp":1172615425000},"page":"e238","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":111,"title":["Proteasome Activator Enhances Survival of Huntington's Disease Neuronal Model Cells"],"prefix":"10.1371","volume":"2","author":[{"given":"Hyemyung","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Christian","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woori","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Isacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2007,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.ne.19.030196.000455","article-title":"Trinucleotide repeats in neurogenetic disorders.","volume":"19","author":"HL Paulson","year":"1996","journal-title":"Annu Rev Neurosci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","article-title":"Huntington's disease genetics.","volume":"1","author":"RH Myers","year":"2004","journal-title":"NeuroRx"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0595-104","article-title":"Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form.","volume":"10","author":"Y Trottier","year":"1995","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/hmg\/ddi064","article-title":"Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.","volume":"14","author":"AB Bowman","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/07853890410031948","article-title":"Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system.","volume":"36","author":"L Petrucelli","year":"2004","journal-title":"Ann Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/hmg\/ddh188","article-title":"Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.","volume":"13","author":"R de Pril","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1146\/annurev.bi.65.070196.004101","article-title":"Structure and functions of the 20S and 26S proteasomes.","volume":"65","author":"O Coux","year":"1996","journal-title":"Annu Rev Biochem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/bse0410157","article-title":"The ubiquitin-proteasome system and neurodegenerative disorders.","volume":"41","author":"R Layfield","year":"2005","journal-title":"Essays Biochem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.20207","article-title":"Generalized brain and skin proteasome inhibition in Huntington's disease.","volume":"56","author":"H Seo","year":"2004","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0076-6879(05)98027-0","article-title":"Purification, crystallization, and X-ray analysis of the yeast 20S proteasome.","volume":"398","author":"M Groll","year":"2005","journal-title":"Methods Enzymol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/80992","article-title":"A gated channel into the proteasome core particle.","volume":"7","author":"M Groll","year":"2000","journal-title":"Nat Struct Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1074\/jbc.M509043200","article-title":"Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate.","volume":"281","author":"AF Kisselev","year":"2006","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"35869","DOI":"10.1074\/jbc.M303725200","article-title":"The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites.","volume":"278","author":"AF Kisselev","year":"2003","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3450001","article-title":"The proteasome activator 11 S REG (PA28) and class I antigen presentation.","volume":"1","author":"M Rechsteiner","year":"2000","journal-title":"Biochem J 345 Pt"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"22123","DOI":"10.1074\/jbc.274.32.22123","article-title":"The proteasome, a novel protease regulated by multiple mechanisms.","volume":"274","author":"GN DeMartino","year":"1999","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses.","volume":"11","author":"S Sipione","year":"2002","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"29660","DOI":"10.1074\/jbc.270.50.29660","article-title":"Inhibition of ubiquitin-mediated proteolysis by the Arabidopsis 26 S protease subunit S5a.","volume":"270","author":"Q Deveraux","year":"1995","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"20878","DOI":"10.1016\/S0021-9258(17)31904-X","article-title":"PA700, an ATP-dependent activator of the 20 S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family.","volume":"269","author":"GN DeMartino","year":"1994","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/095535491820873191","article-title":"Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture.","volume":"3","author":"AH Cory","year":"1991","journal-title":"Cancer Commun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.","volume":"101","author":"A Yamamoto","year":"2000","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1523\/JNEUROSCI.21-22-08772.2001","article-title":"Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.","volume":"21","author":"E Martin-Aparicio","year":"2001","journal-title":"J Neurosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-5793(03)00353-3","article-title":"Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism.","volume":"542","author":"M Demasi","year":"2003","journal-title":"FEBS Lett"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/hmg\/8.4.673","article-title":"Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3\/MJD and suppression of polyglutamine aggregation in vitro.","volume":"8","author":"Y Chai","year":"1999","journal-title":"Hum Mol Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.0511316103","article-title":"Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH.","volume":"103","author":"BI Bae","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1471-4159.2004.02376.x","article-title":"Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.","volume":"89","author":"MD Kaytor","year":"2004","journal-title":"J Neurochem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm1076","article-title":"RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.","volume":"10","author":"H Xia","year":"2004","journal-title":"Nat Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.200510065","article-title":"Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway.","volume":"172","author":"A Yamamoto","year":"2006","journal-title":"J Cell Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.1124514","article-title":"Progressive disruption of cellular protein folding in models of polyglutamine diseases.","volume":"311","author":"T Gidalevitz","year":"2006","journal-title":"Science"},{"key":"ref29","article-title":"Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.","author":"M Diaz-Hernandez","year":"2006","journal-title":"J Neurochem."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1750-3639.2003.tb00491.x","article-title":"Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases?","volume":"13","author":"HG Lee","year":"2003","journal-title":"Brain Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.","volume":"41","author":"SE Browne","year":"1997","journal-title":"Ann Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/hmg\/ddh082","article-title":"Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway.","volume":"13","author":"Q Ruan","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.","volume":"321","author":"MF Beal","year":"1986","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1523\/JNEUROSCI.08-10-03901.1988","article-title":"Systemic approaches to modifying quinolinic acid striatal lesions in rats.","volume":"8","author":"MF Beal","year":"1988","journal-title":"J Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/syn.890030410","article-title":"Short- and long-term survival of large neurons in the excitotoxic lesioned rat caudate nucleus: a light and electron microscopic study.","volume":"3","author":"RC Roberts","year":"1989","journal-title":"Synapse"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.4049\/jimmunol.172.6.3948","article-title":"Immune defects in 28-kDa proteasome activator gamma-deficient mice.","volume":"172","author":"LF Barton","year":"2004","journal-title":"J Immunol"},{"key":"ref37","first-page":"193","article-title":"Relationships between stress protein induction and NMDA-mediated neuronal death in the entorhinal cortex.","volume":"94","author":"WM Yee","year":"1993","journal-title":"Exp Brain Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.2006.03814.x","article-title":"Quinolinic acid modulates the activity of src family kinases in rat striatum: in vivo and in vitro studies.","volume":"97","author":"A Metere","year":"2006","journal-title":"J Neurochem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/exnr.1993.1071","article-title":"Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum.","volume":"121","author":"JR Simpson","year":"1993","journal-title":"Exp Neurol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease.","volume":"95","author":"E Brouillet","year":"2005","journal-title":"J Neurochem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1096\/fj.05-5085fje","article-title":"Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation.","volume":"20","author":"C Jacquard","year":"2006","journal-title":"Faseb J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1091\/mbc.8.1.171","article-title":"Yeast counterparts of subunits S5a and p58 (S3) of the human 26S proteasome are encoded by two multicopy suppressors of nin1-1.","volume":"8","author":"K Kominami","year":"1997","journal-title":"Mol Biol Cell"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0300-9084(01)01236-6","article-title":"Molecular dissection of the 11S REG (PA28) proteasome activators.","volume":"83","author":"J Li","year":"2001","journal-title":"Biochimie"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.","volume":"82","author":"MH Glickman","year":"2002","journal-title":"Physiol Rev"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/hmg\/ddi423","article-title":"Proteasome impairment does not contribute to pathogenesis in R6\/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.","volume":"15","author":"JS Bett","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref46","article-title":"Generalized ubiquitin proteasome inhibitiion in Huntington's disease patients' brains is modeled in some but not all HD transgenic mice.","author":"H Seo","year":"2005","journal-title":"Annual conference of Society for Neuroscience"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity.","volume":"96","author":"O Hansson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.","volume":"72","author":"R Zufferey","year":"1998","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild-type huntingtin protects from apoptosis upstream of caspase-3.","volume":"20","author":"D Rigamonti","year":"2000","journal-title":"J Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"13437","DOI":"10.1074\/jbc.272.20.13437","article-title":"Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation.","volume":"272","author":"A Craiu","year":"1997","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0000238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T07:56:41Z","timestamp":1707638201000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0000238"}},"subtitle":[],"editor":[{"given":"Mark","family":"Cookson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,2,28]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0000238","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,28]]}}}